|
4 documents found matching dt:flow chart.
|
|
Prev
Next
|
|
|
|
Showing 1-4 of 4 documents
|
1.
Publication Approval Process
|
Document Date:
|
00000000
|
|
Page Count:
|
1
|
|
Search Terms in Context:
|
Publication Approval Process
Preclinical
20 days
10 days
\
5 days
5 days
2 days
, 34 days
5 days
2 days
5 days
i
*On all request for abstracts, posters & publications.
please copy D. Downey. S. Olivier. S. Spielmann.
G. Grubb. B. Reiss. R. Besthof & D. Dubinski
Confidential Pursuant to Confidentiality Order
WINNR201-009396
pgNbr=1
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/xkc37b10
|
|
| |
2.
1995 Epilepsy Business Plan
|
Document Date:
|
19950000
|
|
Corporate Author:
|
Parke-Davis
|
|
Search Terms in Context:
|
. © $8.24 PLUS CERTIFICATE
TODAY SCHD. PAD@ $3.71
MEX. STUDY RPT ® $11.39
FORMULARY KIT © $21.86
CHF PATIENT BK ® $3.14
FORMULARY CARD ® $3.44
CHF!HTN DOSING ® $4.08 CHART
pgNbr=15
$0.00
so.00
so.00
so.00
$o.00
$0.00
$0.00
so.00
$0.00
so.00
so.00
so.00
so.00
$0.00
$0.00
so.00
BUSINESS CARD a $2.37 HOLDER
PDR INSERT FLD. ® $7.97
5MG SMPL STICKER Q $2.34
NOTE HOLDER © $1.53
LABELS a $2.27
SMPL
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/aib00a10
|
|
| |
3.
Epilepsy Awareness & Support Exchange
|
Document Date:
|
00000000
|
|
Search Terms in Context:
|
c
pgNbr=1
EPILEPSY AWARENESS &
SUPPORT EXCHANGE
pgNbr=2
Epilepsy Awareness & Support Exchange
Market Research
Patients/Caregivers
- Need and desire epilepsy information -.Lack access or knowledge of support services
- Desire to 'remain anonymous
Physicians
- Lack time, knowledge or desire to provide "adequate" epilepsy information to patients/caregivers
- Lack knowledge of epilepsy support organizations
- Desire to offer patients easy access to information and support services
pgNbr=3
J
Program Overview
Key issues to resolve include:
Are AED user lists accessible via key acccounts?
Is personalized & customized coop mailing feasible?
- Are there enhancements. that have beeen overlooked?
- Are there program options besides coop mail?
How much pharmacist cooperation will be necessary?
Is pharmacist cooperation obtainable?
- What other testing issues will key accounts need measured?
- How much lead time will be necessary for key customers?
Can P-D continue contact with EASE members enrolled via key custo
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/nea00a10
|
|
| |
4.
Neurontin Marketing Assessments
|
Document Date:
|
19950731
|
|
Author:
|
Brandicourt, O
|
|
Corporate Author:
|
Parke-Davis
|
|
Search Terms in Context:
|
26
pgNbr=1
20' 'aoor Roan °none 201.540-2000 Mc.. 5 Pans N..
42 PARKE-DAViS
-:.oral ,.'vnz, Care
DISTRIBUTION July 31, 1995
O. Brandicourt, M.D. (PD. Product Planning, Morris Plains, NJ USA) Neurontin0 Marketinq Assessments
Enclosed is the final version of the Marketing Assessment for Neurontin® in neuropathic pain and spasticity.
The results of the recommended exploratory trials in neuropathic pain, if positive, will be publicized in medical congresses and published, but there is no intention to fully develop this indication at this point. No investment is recommended for spasticity.
OB:nrb
neu-npp.all
Enclosure
WL 07520
O.ns,on of wane-Lamoe' Comoany
CONFIDENTIAL
O. Brandicourt
pgNbr=2
4
DISTRIBUTION:
Development Team: A. Blumberg
H. Bockbrader
J. Boonstra
J. Boris
A. Brankiewicz
M. Dong
K. Fisher E. Garofalo
K. Harris
L. Magnus-Miller R. Martin G. Murray C. Taylor J. Turner
L. Ulrich R. Walker J. Zeller
cc: J. Montgomery
A. Pande (Ann Arbor)
M. Pierce (Ann Arbor)
L. Perlow J. Pieroni
I. Summers (Europe
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/qhb00a10
|
|
| |
|
Prev
Next
|
